🟢 Veraxa Biotech is trading 6.38% up in pre-market amid broader biotech strength

Veraxa Biotech is trading 6.38% higher at $1.50 in pre-market following broader biotechnology strength; no company-specific catalyst was identified.

• Shares closed at $1.41 on September 24, 2026.
• XBI was reported up 2.61% pre-market.
• A September 24 report discussed pipeline advancement and financing support but did not directly attribute the move to that update. No new company announcement, earnings release, or regulatory catalyst was identified for September 25.